We are aware of the unavailability of Ryzodeg 70/30 FlexTouch insulin prefilled pens. Novo Nordisk, the supplier of Ryzodeg in Australia, has notified us of its decision to discontinue marketing Ryzodeg 70/30 FlexTouch insulin prefilled pens from 1 February 2025. Ryzodeg FlexTouch has been in short supply since 30 June 2023.
To help manage the shortage and upcoming discontinuation, we have made a Serious Scarcity Substitution Instrument. This means that pharmacists can give patients Ryzodeg 70/30 Penfill cartridges instead of Ryzodeg 70/30 FlexTouch prefilled pens under certain conditions. Both products contain the same medicine, at the same strength, have the same storage requirements, and are administered by injection under the skin (subcutaneous injection). However, the device used to administer the medicine is different.
For detailed information and to find out what you should do, visit About the shortage of Ryzodeg 70/30 FlexTouch insulin prefilled pens.